In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition
Scientific Reports · 2025
DOI: 10.1038/s41598-024-84697-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2025. Verfasst von Priscila Goes Camargo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina, PR, Brasil. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Molecular Docking Simulation, Molecular Dynamics Simulation, Trypanocidal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
This work investigates the anti-trypanosomal activities of ten thiohydantoin derivatives against the parasite Trypanosoma cruzi. Compounds with aliphatic chains (THD1, THD3, and THD5) exhibited the most promising IC50 against the epimastigote form of T. cruzi. Also, it showed lower cytotoxicity to mammalian cells. THD3 and THD5 (IC50 = 72.4 µg/mL and 115 µg/mL) presented great activity against trypomastigote and amastigote forms (IC50 = 47.7 µg/mL and 34.1 µg/mL). THD5 had high selectivity index (SI = 15.1) against the amastigote form. The molecular docking and molecular dynamics simulations were performed to understand the interaction between the THD and the important target CYP51 enzyme essential to T. cruzi. THD3 and THD5 were found to have strong interactions within the hydrophobic channel of CYP51 due to their aliphatic side chains, leading to favorable binding free energies. Despite the possibility of cross-reactivity between THD5 and human CYP2C9, the results indicate low identity and similarity between the homolog enzymes and possible selectivity of THD5 for the protozoan one, suggesting that these compounds could inhibit sterol biosynthesis, crucial for the parasite's survival. These findings indicate that THD3 and THD5 are promising hits for the development of Chagas disease treatments. To fully validate this potential, carrying out enzymatic and other in vitro and in vivo assays is essential in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina, PR, Brasil.
- Faculdade de Farmácia, Departamento de Fármacos e Medicamentos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, PR, Brasil.
- Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
- Departamento de Química, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina, PR, Brasil. mlfbispo@uel.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Camargo, P. G., Suzukawa, H. T., Pereira, P. M. L., Silva, M. L., Macedo, F., Albuquerque, M. G., Rodrigues, C. R., Yamada-Ogatta, S. F., da Silva Lima, C. H., & Bispo, M. L. F. (2025). In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition. Scientific Reports. https://doi.org/10.1038/s41598-024-84697-2
Vancouver
Camargo PG, Suzukawa HT, Pereira PML, Silva ML, Macedo F, Albuquerque MG, et al. In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition. Scientific Reports. 2025. doi:10.1038/s41598-024-84697-2
BibTeX
@article{Camargo2025,
author = {Camargo, Priscila Goes and Suzukawa, Helena Tiemi and Pereira, Patrícia Morais Lopes and Silva, Mariana Luiza and Macedo, Fernando and Albuquerque, Magaly Girão and Rodrigues, Carlos Rangel and Yamada-Ogatta, Sueli Fumie and da Silva Lima, Camilo Henrique and Bispo, Marcelle de Lima Ferreira},
title = {In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition},
journal = {Scientific Reports},
year = {2025},
doi = {10.1038/s41598-024-84697-2}
}
EUVIMED